EcoDrugPlus

Plasminogen

Ensembl ID : ENSNFUG00015001723
Gene Symbol: PLG
3 Cross references
248 Possible Orthologues:

Plasminogen Activator, Tissue Type

Ensembl ID : ENSNFUG00015016559
Gene Symbol: PLAT
3 Cross references
205 Possible Orthologues:

Platelet Activating Factor Receptor

Ensembl ID : ENSNFUG00015005216
Gene Symbol: PTAFR
3 Cross references
224 Possible Orthologues:

Platelet Derived Growth Factor Receptor Alpha

Ensembl ID : ENSNFUG00015011936
Gene Symbol: PDGFRA
3 Cross references
203 Possible Orthologues:

Platelet Derived Growth Factor Receptor Beta

Ensembl ID : ENSNFUG00015013252
Gene Symbol: PDGFRB
3 Cross references
198 Possible Orthologues:

Polo Like Kinase 1

Ensembl ID : ENSNFUG00015000714
Gene Symbol: PLK1
1 Cross references
188 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 1

Ensembl ID : ENSNFUG00015004671
Gene Symbol: PARP1
3 Cross references
209 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 2

Ensembl ID : ENSNFUG00015022770
Gene Symbol: PARP2
3 Cross references
185 Possible Orthologues:

Poly(Adp-Ribose) Polymerase Family Member 3

Ensembl ID : ENSNFUG00015019880
Gene Symbol: LOC107385736
3 Cross references
206 Possible Orthologues:

Porcupine O-Acyltransferase

Ensembl ID : ENSNFUG00015015869
Gene Symbol: PORCN
1 Cross references
197 Possible Orthologues:

Porcupine O-Acyltransferase

Ensembl ID : ENSNFUG00015020872
Gene Symbol: PORCN
1 Cross references
193 Possible Orthologues:

Potassium Calcium-Activated Channel Subfamily M Alpha 1

Ensembl ID : ENSNFUG00015023512
Gene Symbol: KCNMA1
1 Cross references
235 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).